Study to identify novel drivers of platelet production in platelet apheresis donors

ISRCTN ISRCTN95084335
DOI https://doi.org/10.1186/ISRCTN95084335
Secondary identifying numbers V2.0
Submission date
20/06/2014
Registration date
08/07/2014
Last edited
15/10/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Haematological Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
When people donate their blood platelets, they lose about 50% of them. Although this is perfectly safe, it is not clear how quickly their platelet count returns to normal and what causes this to happen: it’s possible that new platelets come from a “reserve pool” in the spleen and/or they are made by bone marrow. It is also not known what chemicals (growth factors) in the blood stream are important in making sure the number of platelets return to normal after donation. Knowing what these “platelet” growth factors are would be extremely useful for the treatment of patients with low platelet counts or in making platelets in the laboratory for transfusion. This study compares how quickly the number of platelets return to normal and what growth factors are present in regular donors verses people who are about to donate for the first time.

Who can participate?
Adult male platelet donors who regularly donate at the Cambridge Blood Centre and those that are due to donate for the first time.

What does the study involve?
A blood sample is taken from each participant 30 minutes before the platelet donation begins, in the opposite arm to which the donation is taken from. Another sample is taken 10 minutes after the donation is complete, one 4-8 hours after donation and then a number of additional samples on days 1,3,7 and 14 after the donation are taken. Donors are given the choice whether they would like the bloods to be done at home, place of work or at the Blood Centre.

What are the possible benefits and risks of participating?
There are no significant benefits or risks to taking part in this study. Donations take around 40 minutes longer than a normal platelet donation. The blood sampling may cause some mild discomfort and sometimes a small bruise.

When is the study starting and how long is it expected to run for?
September 2014 to September 2015

Who is funding the study?
NHS Blood and Transplant Trust Fund (UK)

Who is the main contact?
Cedric Ghevaert
cg348@cam.ac.uk

Contact information

Dr Cedric Ghevaert
Scientific

NHS Blood and Transplant
Cambridge Blood Centre
Long Road
Cambridge
CB2 0PT
United Kingdom

Phone +44 (0)1223 588904
Email cg348@cam.ac.uk

Study information

Study design1-year laboratory study
Primary study designObservational
Secondary study designOther
Study setting(s)Other
Study typeOther
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleReticulated platelet release and mass spectrometry analysis of plasma proteins after apheresis platelet donation by established and new donors
Study objectivesPlatelet donors donate their platelets through a process called apheresis. The donors have a cannula inserted into a vein and this blood line goes into a machine that spins the blood from the donor so as to separate it into different constituents (plasma, red cells, platelets). The red cells and plasma are given back to the donors, whilst the platelets are collected into a bag that can be transfused to a patient. The donation process takes about 1.5 hours. Platelet donors lose about 50% of their platelets, which gradually recover over 2 weeks with the formation of new platelets in the donor’s bone marrow. The hypothesis is that this is driven by growth factors (in addition to thrombopoietin). This study aims to identify the exact dynamics of platelet recovery following platelet donation and correlate it to the presence of plasma-bound growth factors through mass spectrometry
Ethics approval(s)NRES Committee East of England – Cambridge South, 22/05/2014, ref: 14/EE/0194
Health condition(s) or problem(s) studiedPlatelet recovery following donation
InterventionThe donors will have bloods taken pre and post donation and at another four timepoints over the next 2 weeks.
Intervention typeOther
Primary outcome measureThe primary objective of this study will be the accurate measurement of the platelet count, the platelet volume and the quantity of newly formed platelets in platelet apheresis donors at the time of donation and at early (4-8 hours) and late (day 1, 3, 7 and 14) time points after donation. From the same blood sample used to look at the platelet count, the plasma will be isolated and analysed by mass spectrometry to identify which proteins contained in the blood promote new platelets release from the bone marrow.
Secondary outcome measuresPlatelet donors give a donation every 4 weeks. Samples will be taken from established platelet donors and from newly recruited donors to establish whether the platelet count recovery and plasma proteins are different when platelet donations are done frequently.
Overall study start date08/09/2014
Completion date08/09/2015

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
SexMale
Target number of participants30
Key inclusion criteriaMale platelet donors aged over 18 who are able to donate on Monday or Tuesday morning
Key exclusion criteria1. Female donors
2. HPA-1a-5b negative donors who are used to maintain the supply of platelets for treatment of neonatal alloimmune thrombocytopenia
Date of first enrolment08/09/2014
Date of final enrolment08/09/2015

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

NHS Blood and Transplant
Cambridge
CB2 0PT
United Kingdom

Sponsor information

NHS Blood and Transplant Trust Fund (UK)
Hospital/treatment centre

Oak House
Reeds Crescent
Watford
WD24 4QN
England
United Kingdom

Phone +44 (0)1923 366800
Email research.office@nhsbt.nhs.uk
Website http://www.nhsbt.nhs.uk/
ROR logo "ROR" https://ror.org/0227qpa16

Funders

Funder type

Hospital/treatment centre

NHS Blood and Transplant
Government organisation / Local government
Alternative name(s)
National Health Service Blood and Transplant, UK National Health Service Blood and Transplant, NHSBT
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No

Editorial Notes

15/10/2020: No publications found.
09/11/2017: No publications found, verifying study status with principal investigator.